Jennifer Bobb, PhD, aims to apply rigorous statistical methods to address important problems in public health. She is interested in statistical issues that occur when data that were not originally collected for research purposes, such as administrative claims data or electronic health records, are used for addressing scientific questions relevant to clinical practice and health policy.
At Kaiser Permanente Washington Health Research Institute (KPWHRI), Dr. Bobb collaborates with scientists across a broad range of research areas, including mental and behavioral health and social determinants of health. As an investigator with the Health Care Systems Addictions Research Network, she provides statistical leadership on pragmatic clinical trials at Kaiser Permanente Washington and other health systems. She is the lead statistician on a stepped wedge trial evaluating how mental health and wellness integration at Kaiser Permanente Washington affects clinical care and health outcomes, as well as a multi-site pragmatic trial to evaluate a program for increasing medication treatment for opioid use disorders within primary care settings. She has developed statistical guidance to address methodological challenges introduced by pragmatic trials that leverage electronic health records data to define study eligibility and outcomes.
With expertise in environmental biostatistics, Dr. Bobb has led large-scale epidemiological investigations on the health effects of exposure to extreme heat and air pollution. She developed flexible modeling approaches for estimating the health effects of multi-pollutant mixtures that broadly apply to settings where large numbers of exposures may interact or have complex relationships with health, along with publicly available software implementing these methods. In recent work, she is collaborating on the Moving to Health study, which explores whether changes in the built environment, such as access to healthy foods and walkability, affect long-term weight and diabetes management.
Dr. Bobb is an affiliate assistant professor in biostatistics at the University of Washington and an associate editor of the journal Biostatistics. She serves on the Committee for Funded Research of the American Statistical Association and is a member of the International Biometric Society. Before joining KPWHRI, Dr. Bobb completed her PhD in biostatistics at the Johns Hopkins Bloomberg School of Public Health in 2012, followed by a postdoctoral fellowship at the Harvard T.H. Chan School of Public Health.
Bayesian methods; analysis of observational data; pragmatic trial design and analysis; analysis of spatial-temporal data
Biostatistics; implementation science
Biostatistics; behavioral health; alcohol and substance use disorders
Biostatistics; built environment
Health effects of air pollution, extreme weather events; statistical methods for complex environmental mixtures
Prevention and treatment
Williams EC, McGinnis KA, Rubinsky AD, Matson TE, Bobb JF, Lapham GT, Edelman EJ, Satre DD, Catz SL, Richards JE, Bryant KJ, Marshall BDL, Kraemer KL, Crystal S, Gordon AJ, Skanderson M, Fiellin DA, Justice AC, Bradley KA. Alcohol use and antiretroviral adherence among patients living with HIV: is change in alcohol use associated with change in adherence? AIDS Behav. 2020 Jul 2. doi: 10.1007/s10461-020-02950-x. [Epub ahead of print]. PubMed
Mooney SJ, Bobb JF, Hurvitz PM, Anau J, Theis MK, Drewnowski A, Aggarwal A, Gupta S, Rosenberg DE, Cook AJ, Shi X, Lozano P, Moudon AV, Arterburn D. Impact of built environments on body weight (the Moving to Health study): protocol for a retrospective longitudinal observational study. JMIR Res Protoc. 2020 May 19;9(5):e16787. doi: 10.2196/16787. PubMed
Bobb JF, Qiu H, Matthews AG, McCormack J, Bradley KA. Addressing identification bias in the design and analysis of cluster-randomized pragmatic trials: a case study. Trials. 2020;21(1):289. doi: 10.1186/s13063-020-4148-z. PubMed
Boudreau DM, Lapham G, Johnson EA, Bobb JF, Matthews AG, McCormack J, Liu D, Samet JH, Campbell CI, Rossom RC, Binswanger IA, Yarborough BJH, Arnsten JH, Cunningham CO, Glass JE, Murphy MT, Zare M, Hechter R, Ahmedani B, Braciszewski JM, Horigian VE, Szapocznik J, Samet JH, Saxon AJ, Schwartz RP, Bradley KA. Documented opioid use disorder and its treatment in primary care patients across six US health systems. J Subst Abuse Treat. 2020 Mar;112S:41-48. doi: 10.1016/j.jsat.2020.02.001. PubMed
Lapham G, Boudreau DM, Johnson EA, Bobb JF, Matthews AG, McCormack J, Liu D, Samet JH, Saxon AJ, Campbell CI, Glass JE, Rossom RC, Murphy MT, Binswanger IA, Yarborough BJH, Bradley KA. Prevalence and treatment of opioid use disorders among primary care patients in six health systems. Drug Alcohol Depend. 2020;207:107732. doi: 10.1016/j.drugalcdep.2019.107732. Epub 2019 Nov 15. PubMed
Sayre M, Lapham GT, Lee AK, Oliver M, Bobb JF, Caldeiro RM, Bradley KA. Routine Assessment of Symptoms of Substance Use Disorders in Primary Care: Prevalence and Severity of Reported Symptoms. LID - 10.1007/s11606-020-05650-3 [doi] J Gen Intern Med. 2020 Jan 23. pii: 10.1007/s11606-020-05650-3. doi: 10.1007/s11606-020-05650-3 [Epub ahead of print] PubMed
UW/KPWHRI research team confers with King County organizations at its "Moving to Health" Summit, sparking new collaborations.
Dr. Gregory Simon says research is needed to see if this new drug for persistent depression will prevent suicides.
Drs. Lapham and Bradley find frequency of cannabis use can be tied to other behavioral health patterns and needs.